Comparing Two Strategies to Promote Supraglottic Airway Use During Neonatal Resuscitation

What this Trial Is About

Researchers are evaluating two different strategies to increase the use of supraglottic airway (SA) devices during neonatal resuscitation. This trial focuses on improving early SA rescue for newborns who require help establishing breathing at birth. Despite SA being approved and recommended for cases where facemask ventilation is difficult, its use remains low, and the study aims to understand how to better implement SA use in routine care to reduce risks of prolonged asphyxia and improve newborn health outcomes. The trial compares two approaches to support hospitals and providers in adopting SA use. One group receives an Enhanced Standard of Care involving educational materials, outreach, local champions, train-the-trainer programs, simulation training, and starter packs of SA devices. The other group receives all these components plus additional intensive external facilitation to further promote SA adoption. These strategies are delivered at hospital sites and evaluated over time. Participants include hospital staff involved in newborn resuscitation and newborns who receive positive pressure ventilation at birth. Data collection includes questionnaires and interviews with clinical providers and administrators, along with monitoring early SA rescue rates up to two years. The study measures initial adoption and sustainment of SA use, assessing both implementation and clinical outcomes. The trial runs from 2026 to 2029 and aims to identify barriers and facilitators for widespread SA use in delivery rooms.

Supraglottic Airway for Resuscitation Trial